{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:49:52Z","timestamp":1772804992099,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.transproceed.2010.09.173","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T09:14:57Z","timestamp":1292663697000},"page":"4543-4547","source":"Crossref","is-referenced-by-count":20,"title":["Rifaximin for the Treatment of Hepatic Encephalopathy"],"prefix":"10.1016","volume":"42","author":[{"given":"P.S.","family":"Mantry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Munsaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2010.09.173_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.mog.0000158110.13722.e0","article-title":"Portal hypertension","volume":"21","author":"Garcia-Tsao","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.transproceed.2010.09.173_bib2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","author":"Gin\u00e8s","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2010.09.173_bib3","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Hepatic encephalopathy","volume":"96","author":"Blei","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2010.09.173_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000089784","article-title":"Management of hepatic encephalopathy: focus on antibiotic therapy","volume":"73","author":"Festi","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.transproceed.2010.09.173_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1592\/phco.28.8.1019","article-title":"Rifaximin for the treatment of hepatic encephalopathy","volume":"28","author":"Lawrence","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2010.09.173_bib6","first-page":"S10","article-title":"Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety","volume":"5","author":"Williams","year":"2005","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.transproceed.2010.09.173_bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gut.2007.122176","article-title":"Pathogenetic mechanisms of hepatic encephalopathy","volume":"57","author":"H\u00e4ussinger","year":"2008","journal-title":"Gut"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2010.09.173_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2007-984576","article-title":"An algorithm for the management of hepatic encephalopathy","volume":"27","author":"Mullen","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.transproceed.2010.09.173_bib9","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/lt.21129","article-title":"Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease","volume":"13","author":"Stewart","year":"2007","journal-title":"Liver Transpl"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2010.09.173_bib10","first-page":"S3","article-title":"Role of antibiotics in the management of hepatic encephalopathy","volume":"5","author":"Maddrey","year":"2005","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.transproceed.2010.09.173_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14787210.4.3.417","article-title":"Current and future developments in travelers' diarrhea therapy","volume":"4","author":"Koo","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2010.09.173_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","article-title":"Rifaximin: in vitro and in vivo antibacterial activity\u2014a review","volume":"51","author":"Jiang","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.transproceed.2010.09.173_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10620-006-9442-4","article-title":"Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy","volume":"52","author":"Leevy","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2010.09.173_bib14","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1016\/j.transproceed.2006.10.107","article-title":"Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy","volume":"38","author":"Neff","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2010.09.173_bib15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4065\/80.11.1501","article-title":"Influence of recent advances in medical management on clinical outcomes of cirrhosis","volume":"80","author":"Talwalkar","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.transproceed.2010.09.173_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.mcg.0000248018.08515.f9","article-title":"Infections in patients with end-stage liver disease","volume":"41","author":"Cheruvattath","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.transproceed.2010.09.173_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bpg.2006.07.006","article-title":"The future treatment of portal hypertension","volume":"21","author":"Reichen","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"suppl 1","key":"10.1016\/j.transproceed.2010.09.173_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081990","article-title":"Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential","volume":"51","author":"Scarpignato","year":"2005","journal-title":"Chemotherapy"},{"issue":"suppl 2","key":"10.1016\/j.transproceed.2010.09.173_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2007-984572","article-title":"Economic impact of treatment options for hepatic encephalopathy","volume":"27","author":"Leevy","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.transproceed.2010.09.173_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1185\/03007999309111539","article-title":"Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy","volume":"13","author":"Bucci","year":"1993","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.transproceed.2010.09.173_bib21","first-page":"57","article-title":"Rifaximin in the treatment of hepatic encephalopathy","volume":"4","author":"Giacomo","year":"1993","journal-title":"Eur J Clin Res"},{"key":"10.1016\/j.transproceed.2010.09.173_bib22","first-page":"7","article-title":"Treatment of hepatic encephalopathy with rifaximin:double-blind, double-dummy study versus lactulose","volume":"4","author":"Massa","year":"1993","journal-title":"Eur J Clin Res"},{"key":"10.1016\/j.transproceed.2010.09.173_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451001609X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451001609X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T06:20:50Z","timestamp":1544077250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113451001609X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S004113451001609X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2010.09.173","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}